SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
4.860
-0.040 (-0.82%)
At close: Apr 8, 2026, 4:00 PM EDT
4.940
+0.080 (1.65%)
Pre-market: Apr 9, 2026, 7:15 AM EDT
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $348.31 million as of April 9, 2026. Its market cap has increased by 67.04% in one year.
Market Cap
348.31M
Enterprise Value
341.04M
1-Year Change
67.04%
Ranking
Category
Stock Price
$4.86
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $348.31M, a decrease of -68.91%. That is a compound annual growth rate of -21.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 348.31M | 9.93% |
| Dec 31, 2025 | 316.85M | 55.34% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
| Jul 23, 2021 | 1.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HealthStream | 596.81M |
| Phreesia | 531.68M |
| National Research | 392.60M |
| Weave Communications | 385.38M |
| Claritev | 288.51M |
| So-Young International | 287.62M |
| Evolent Health | 285.79M |
| Carlsmed | 267.19M |